Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Signal Transduction >> Protein Phosphorylation >> Ser / Thr Kinases >> Other Kinases
Anti-WNK1 antibody
See all WNK1 products (4) ...
Rabbit polyclonal to WNK1
WB, ELISA, IHC-P, IHC-Frmore details
Reacts with
Mouse, Rat, Human
Synthesized non-phosphopeptide derived from huma WNK1 around the phosphorylation site of threonine 58 (R-H-T-M-D).
EGF-treated 293 cell extract; human breast carcinoma tissue.
Liquid
Store at -20°C. Stable for 12 months at -20°C
Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS (without Mg2+ and Ca2+), 150mM Sodium chloride, pH 7.4
Concentration information loading...
Immunogen affinity purified
Polyclonal
IgG
Signal Transduction >> Protein Phosphorylation >> Ser / Thr Kinases >> Other Kinases
Our Abpromise guarantee covers the use of ab53151 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: 1/300 - 1/1000.Predicted molecular weight: 251 kDa.
ELISA: 1/10000
IHC-P: 1/50 - 1/100.
IHC-Fr: Use at an assay dependent dilution. (PubMed: 20398666)
Controls sodium and chloride ion transport by inhibiting the activity of WNK4, potentially by either phosphorylating the kinase or via an interaction between WNK4 and the autoinhibitory domain of WNK1. WNK4 regulates the activity of the thiazide-sensitive Na-Cl cotransporter, SLC12A3, by phosphorylation. WNK1 may also play a role in actin cytoskeletal reorganization.
Widely expressed, with highest levels observed in the testis, heart, kidney and skeletal muscle. Isoform 3 is kidney-specific.
Defects in WNK1 are a cause of pseudohypoaldosteronism type II (PHAII) [MIM:145260]. PHAII is an autosomal dominant disease characterized by severe hypertension, hyperkalemia, and sensitivity to thiazide diuretics which may result from a chloride shunt in the renal distal nephron.
Defects in WNK1 are a cause of hereditary sensory and autonomic neuropathy type 2A (HSAN2A) [MIM:201300]. A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN2A is an autosomal recessive disorder characterized by impairment of pain, temperature and touch sensation, onset of symptoms in infancy or early childhood, occurrence of distal extremity pathologies (paronychia, whitlows, ulcers, and Charcot joints), frequent amputations, sensory loss that affects all modalities of sensation (lower and upper limbs and perhaps the trunk as well), absence or diminution of tendon reflexes (usually in all limbs), minimal autonomic dysfunction, absence of sensory nerve action potentials, and virtual absence of myelinated fibers with decreased numbers of unmyelinated fibers in sural nerves.
Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. WNK subfamily.
Contains 1 protein kinase domain.
O-glycosylated.
Phosphorylated upon DNA damage, probably by ATM or ATR.
Cytoplasm.
Target information above from: UniProt accessionQ9H4A3
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Immunohistochemistry (Paraffin-embedded sections) - WNK1 antibody (ab53151)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue with ab53151 at a dilution of 1/50-1/100. Right hand image: treated with immunising peptide. Left hand image: untreated.
Western blot - WNK1 antibody (ab53151)

All lanes : Anti-WNK1 antibody (ab53151) at 1/300 dilution
Lane 1 : Extracts from 293 cells treated with EGF (200ng/ml, 30 min) with no peptide
Lane 2 : Extracts from 293 cells treated with EGF (200ng/ml, 30 min) with peptide
Predicted band size : 251 kDa
This product has been referenced in:
See 1 publication for this product
Publishing research using ab53151? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:

Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue with ab53151 at a dilution of 1/50-1/100. Right hand image: treated with immunising peptide. Left hand image: untreated.

All lanes : Anti-WNK1 antibody (ab53151) at 1/300 dilution
Lane 1 : Extracts from 293 cells treated with EGF (200ng/ml, 30 min) with no peptide
Lane 2 : Extracts from 293 cells treated with EGF (200ng/ml, 30 min) with peptide
Predicted band size : 251 kDa
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
